Form D · Other

J2 Health, Inc.

New York, NY · CIK 0002064452

Offering snapshot reported Apr 28, 2025 · SEC filing

Reported sold
$1.01M
Offering amount: $1.01M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 12, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2025Initial$1,008,690No comparison5SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-544620
SAFEs, and the Equity Securities Issuable upon conversion of such SAFEs.

Source: Form D, filed Apr 28, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

PRCNR I JUNE 2025, A SERIES OF SECONDMARKET GROWTH, LLC

Investment adviser: SECONDMARKET FINANCIAL, LLC

Gross asset value
$1.58M
Beneficial owners
5
ADV minimum commitment
$100K

Reported in Form ADV on Jul 9, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SYDECAR LLC CLAYMONT, Delaware, United States Investor statements: No (provided to no investors) Related to adviser: No
Auditor CITRIN COOPERMAN & COMPANY, LLP NEW YORK, New York, United States
Custodian GRASSHOPPER BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Marketer NPM SECURITIES, LLC NEW YORK, New York, United States Related to adviser: Yes
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

CITRIN COOPERMAN & COMPANY, LLP
PCAOB 2468

GRASSHOPPER BANK, N.A.
LEI 254900WTRW9X2ZN1UG04

NPM SECURITIES, LLC
CRD 168469 · SEC 8-69312

Filing source

Form ADV 2118582 · Jul 9, 2026 · Schedule D 7.B.(1), fund 805-2631470532

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joshua Poretz Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
244 5 Th Avenue Suite A241
New York, NY, 10001